*	OR T2 T3
R1	Has_mood Arg1:T6 Arg2:T5	
R2	Has_negation Arg1:T5 Arg2:T4	
*	OR T10 T9 T8
*	OR T12 T11
R3	Has_mood Arg1:T10 Arg2:T12	
*	OR T15 T16
*	OR T20 T19
R4	Has_qualifier Arg1:T21 Arg2:T22	
R5	AND Arg1:T21 Arg2:T20	
*	OR T17 T21
R6	Has_temporal Arg1:T17 Arg2:T18	
*	OR T25 T27 T28 T26
R7	AND Arg1:T29 Arg2:T30	
R9	Has_multiplier Arg1:T35 Arg2:T36	
R10	Has_qualifier Arg1:T34 Arg2:T33	
R11	AND Arg1:T34 Arg2:T35	
R12	Has_value Arg1:T40 Arg2:T41	
R13	Has_qualifier Arg1:T39 Arg2:T38	
R14	Subsumes Arg1:T39 Arg2:T40	
R15	Has_temporal Arg1:T44 Arg2:T43	
R16	Has_index Arg1:T46 Arg2:T47	
R17	AND Arg1:T47 Arg2:T48	
R18	Has_temporal Arg1:T45 Arg2:T46	
*	OR T50 T51
R19	AND Arg1:T49 Arg2:T50	
*	OR T53 T57 T56 T55 T54 T58
R20	Subsumes Arg1:T49 Arg2:T53	
*	OR T63 T64 T65
R21	Has_qualifier Arg1:T63 Arg2:T62	
*	OR T70 T68 T69
R22	Has_qualifier Arg1:T67 Arg2:T70	
T1	Person 0 7	Females
T2	Condition 16 24	pregnant
T3	Condition 28 35	nursing
T4	Negation 47 50	not
T5	Mood 51 60	scheduled
T6	Procedure 65 91	trans-jugular liver biopsy
T7	Non-query-able 93 237	Patients who have received an investigational drug in the 30 days before study drug administration, or will receive one within 72 h afterwards,.
T8	Condition 306 344	transient right-to-left cardiac shunts
T9	Condition 287 301;330 344	bi-directional cardiac shunts
T10	Condition 272 285;330 344	right-to-left cardiac shunts
T11	Mood 262 271	suspected
T12	Mood 253 258	known
T15	Condition 360 382	pulmonary hypertension
T16	Condition 386 421	unstable cardiopulmonary conditions
T17	Procedure 445 457	chemotherapy
T18	Temporal 432 441	currently
T19	Procedure 510 541	hepatic loco-regional treatment
T20	Procedure 498 506;518 541	systemic loco-regional treatment
T21	Condition 472 487	primary cancers
T22	Qualifier 466 471	other
T25	Condition 561 579	medically unstable
T26	Condition 598 607;622 625	seriously ill
T27	Condition 611 625	terminally ill
T28	Condition 646 678	clinical course is unpredictable
T29	Procedure 706 718	life support
T30	Visit 727 745	critical care unit
T31	Condition 762 788	unstable occlusive disease
T33	Qualifier 829 848	clinically unstable
T34	Condition 849 868	cardiac arrhythmias
T35	Condition 888 911	ventricular tachycardia
T36	Multiplier 878 887	recurrent
T38	Qualifier 928 940	uncontrolled
T39	Condition 941 965	congestive heart failure
T40	Measurement 967 971	NYHA
T41	Value 972 980	Class IV
T43	Temporal 997 1003	recent
T44	Condition 1004 1023	cerebral hemorrhage
T45	Procedure 1054 1061	surgery
T46	Temporal 1062 1120	within 24 hours prior to the study sonographic examination
T47	Reference_point 1087 1120	the study sonographic examination
T48	Procedure 1097 1120	sonographic examination
T49	Condition 1150 1170	anaphylactic allergy
T50	Drug 1174 1178	eggs
T51	Drug 1182 1194	egg products
T53	Condition 1249 1270	generalized urticaria
T54	Condition 1272 1295	difficulty in breathing
T55	Condition 1297 1318	swelling of the mouth
T56	Condition 1297 1312;1323 1329	swelling of the throat
T57	Condition 1331 1342	hypotension
T58	Condition 1347 1352	shock
T61	Condition 1545 1569	congenital heart defects
T62	Qualifier 1586 1592	severe
T63	Condition 1593 1602	emphysema
T64	Condition 1604 1624	pulmonary vasculitis
T65	Condition 1642 1658	pulmonary emboli
T66	Condition 1675 1704	respiratory distress syndrome
T67	Condition 1720 1730	thrombosis
T68	Qualifier 1762 1778	mesenteric veins
T69	Qualifier 1751 1757;1773 1778	portal veins
T70	Qualifier 1742 1749;1773 1778	hepatic veins
